CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts Annotations Abstract Library Committee Members
 
HBV-Single Disease Content  
Featured Article


Webcasts
     
Hepatitis B and D Infection   Educational Webcast
HBV/HDV Hot Topics & Virtual Roundtable   Educational Webcast
HBV, HCV, and HDV   Educational Webcast
 
 
Slide Library
   Released: 2023
Webcast
Stopping All Therapy in HBV Clinical Trials: What Should Be the Criteria for Discontinuation
23 slides
 
 
   Released: 2023
Webcast
New Insights Into The Biology Of HDV: Implications For Drug Development
42 slides
 
 
   Released: 2023
Webcast
HBV Overview of the Last 3 Years For Drug Development: Phase 2 Trials
43 slides
 
 
   Released: 2023
Webcast
Emerging Therapies for HBV in the Next Three Years (Pre-clinical to Phase 1)
31 slides
 
 
   Released: 2023
Webcast
What Are the Most Promising Immunomodulatory Therapies for HBV Infection?
29 slides
 
 
   Released: 2023
Webcast
Emerging Concepts and Data CpAMS Third and Fourth Generation
33 slides
 
 
   Released: 2023
Webcast
Does the New Data on HBV DNA Integration and HBsAg Production Effect the Design and Definition of Treatment Endpoints of Phase II and Phase III Studies?
20 slides
 
 
   Released: 2023
Webcast
Is there a real difference between ETV and TDF/TAF in relapse and HCC?
27 slides
 
 
   Released: 2023
Webcast
How Do We Fit FNA and Liver Biopsy Into HBV Drug Development and Design? Should All Studies Have FNA Subset and Examine Intrahepatic Immune Activity? CccDNA? Integrants?
19 slides
 
 
   Released: 2023
Webcast
Should All Patients With HDV Be Treated?
22 slides
 
 
   Released: 2023
Webcast
HDV Update: Review of the Last 3 Years
18 slides
 
 
   Released: 2023
Webcast
Hepatitis Delta: How Should Bulevirtide Be Used in Clinical Practice
27 slides
 
 
   Released: 2023
Webcast
What Other Therapies Are Being Developed for HDV Infection? NAPS, Lambda, and Lonafarnib
36 slides
 
 
   Released: 2023
Webcast
What Is the Role of Interferon Therapy in HDV?
30 slides
 
 
   Released: 2021
Webcast
HBV Alliance: Expert Recommendations on Managing Patients with Chronic Hepatitis B
56 slides
 
 
   Released: 2021
Webcast
Acute HBV
17 slides
 
 
   Released: 2021
Webcast
Chemotherapy/Reactivation
26 slides
 
 
   Released: 2021
Webcast
Current Management of Chronic Hepatitis B
30 slides
 
 
   Released: 2021
Webcast
Epidemiology of HBV
34 slides
 
 
   Released: 2021
Webcast
Evaluation of the Patient With Chronic HBV
26 slides
 
 
   Released: 2021
Webcast
Everything Old Is New Again!
41 slides
 
 
   Released: 2021
Webcast
Extrahepatic Manifestations of Hepatitis B
34 slides
 
 
   Released: 2021
Webcast
HBsAg Quant HBV Genotyping HBV RNA Quant Where We Are in 2020
41 slides
 
 
   Released: 2021
Webcast
HBV & Hepatitis D (Delta)
26 slides
 
 
   Released: 2021
Webcast
HBV and Liver Cancer
34 slides
 
 
   Released: 2021
Webcast
HBV and NAFLD
35 slides
 
 
   Released: 2021
Webcast
HBV Coinfection With HCV or HIV
35 slides
 
 
   Released: 2021
Webcast
HBV: New Therapies & Clinical Trials
37 slides
 
 
   Released: 2021
Webcast
Hepatitis B Screening: CDC, AASLD, USPSTF
24 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Treatment Endpoints
27 slides
 
 
   Released: 2021
Webcast
Hepatitis B: Update on Treatment Guidelines
27 slides
 
 
   Released: 2021
Webcast
How to Diagnose Hepatitis B
25 slides
 
 
   Released: 2021
Webcast
Immunization for HBV
31 slides
 
 
   Released: 2021
Webcast
Management of HBV: New Data
26 slides
 
 
   Released: 2021
Webcast
Natural History of HBV
39 slides
 
 
   Released: 2021
Webcast
Treatment of Hepatitis B: Controversies 2020
63 slides
 
 
   Released: 2021
Webcast
Update on Hepatitis B
54 slides
 
 
   Released: 2021
Webcast
WHO Hepatitis Elimination Targets
46 slides
 
 
   
     
 
 
 
Annotated Bibliography
1.Safety, Tolerability And Antiviral Activity Of The Antisense Oligonucleotide Bepirovirsen In Patients With Chronic Hepatitis B: A Phase 2 Randomized Controlled Trial
 

Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.

Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
 
2.Critical Updates on Chronic Hepatitis B Virus Infection in 2021
 

Cureus. 2021 Oct 30;13(10):e19152. doi: 10.7759/cureus.19152.eCollection 2021 Oct.

Cyriac A Philips 1, Rizwan Ahamed 2, Jinsha K Abduljaleel 2, Sasidharan Rajesh 3, Philip Augustine 2
 
3.New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection
 

Clin Liver Dis. 2021 Nov;25(4):831-839. doi: 10.1016/j.cld.2021.06.011.Epub 2021 Aug 8.

Lisa Sandmann 1, Heiner Wedemeyer 2
 
4.Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B
 

Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
 
 
 
 
Abstract Library
1.Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B
 

Viruses. 2023 Apr 18;15(4):997. doi: 10.3390/v15040997.

Young-Suk Lim 1, W Ray Kim 2, Douglas Dieterich 3, Jia-Horng Kao 4 5, John F Flaherty 6, Leland J Yee 6, Lewis R Roberts 7, Homie Razavi 8, Patrick T F Kennedy 9
 
2.Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis
 

 Surg Res. 2023 Mar;283:1078-1090. doi: 10.1016/j.jss.2022.10.078.Epub 2022 Dec 15.

Colin C Yost 1, Diana C Jimenez 1, Matthew P Weber 1, Elizabeth J Maynes 1, Katherine A Belden 2, Vakhtang Tchantchaleishvili 1, H Todd Massey 1, David A Sass 3, J Eduardo Rame 4, John J Zurlo 2, Nana Aburjania 5
 
3.Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities
 

Am J Transplant. 2023 Apr 26;S1600-6135(23)00428-8. doi: 10.1016/j.ajt.2023.04.024.Online ahead of print.

Anshul Bhatnagar 1, Sameer Prakash 2, Peter Lymberopoulos 3, Cameron Goff 1, Anjiya Shaikh 4, Donghee Kim 5, Aijaz Ahmed 5, Carl Berg 6, Susanna Naggie 7, Fasiha Kanwal 8, George Cholankeril 9, Tzu-Hao Lee 10
 
4.Effectiveness of Hepatitis B Vaccination for Patients With Inflammatory Bowel and Celiac Disease
 

Clin Gastroenterol Hepatol. 2023 Mar 31;S1542-3565(23)00233-1.doi: 10.1016/j.cgh.2023.03.025. Online ahead of print.

Jessica A Ulrich 1, Nawras W Habash 1, Yasmine A Ismail 1, William J Tremaine 2, Amy L Weaver 3, Joseph A Murray 2, Edward V Loftus Jr 2, Imad Absah 4
 
5.Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
 

Ann Hepatol. 2023 Mar-Apr;28(2):100891.doi: 10.1016/j.aohep.2022.100891. Epub 2022 Dec 24.

Roseane P Medeiros 1, Norah A Terrault 2, Daniel F Mazo 1, Claudia P Oliveira 1, Jennifer Dodge 3, Patricia M Zitelli 1, Marta H Lopes 1, Flair J Carrilho 1, Mário G Pessoa 4
 
6.The Global Burden of Liver Disease
 

Clin Gastroenterol Hepatol. 2023 Apr 28;S1542-3565(23)00315-4.doi: 10.1016/j.cgh.2023.04.015. Online ahead of print.

Zobair M Younossi 1, Grace Wong 2, Quentin M Anstee 3, Linda Henry 4
 
7.Prevention of Perinatal Hepatitis B Transmission
 

Obstet Gynecol Clin North Am. 2023 Jun;50(2):349-361.doi: 10.1016/j.ogc.2023.02.007. Epub 2023 Apr 4.

David M Higgins 1, Sean T O'Leary 2
 
8.New perspectives on development of curative strategies for chronic hepatitis B
 

Clin Gastroenterol Hepatol. 2023 Apr 18;S1542-3565(23)00279-3.doi: 10.1016/j.cgh.2023.02.032. Online ahead of print.

Jordan J Feld 1, Anna S Lok 2, Fabien Zoulim 3
 
9.Hepatitis B and C in individuals with a history of antipsychotic medication use: A population-based evaluation
 

PLoS One. 2023 Apr 14;18(4):e0284323. doi: 10.1371/journal.pone.0284323. eCollection 2023.

Amnah Awan 1, Sharara Shakik 1, Hailey R Banack 1, David N Fisman 1, Alison E Simmons 1
 
10.Hepatitis B immune status of staff in smaller acute healthcare facilities
 

Aust Health Rev. 2023 Apr;47(2):254-257. doi: 10.1071/AH22219.

Alex Hoskins 1, Leon James Worth 2, Michael James Malloy 1, Katherine Walker 1, Ann Bull 1, Noleen Bennett 3
 
11.Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center
 

United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376.Epub 2023 Mar 25.

Mathias Jachs 1, Raphael Sauberer 1, Alexander Stiegler 1, Anton Dechêne 1, Raphael Tazreiter 1, Lukas Hartl 1, David Bauer 1, Lorenz Balcar 1, Robert Strassl 2, Mattias Mandorfer 1, Michael Trauner 1, Petra Munda 1, Peter Ferenci 1, Thomas Reiberger 1
 
12.A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
 

J Hepatol. 2023 May;78(5):926-936.doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28.

Florian van Bömmel 1, Kerstin Stein 2, Renate Heyne 3, Jörg Petersen 4, Peter Buggisch 4, Christoph Berg 5, Stefan Zeuzem 6, Andreas Stallmach 7, Martin Sprinzl 8, Eckart Schott 9, Anita Pathil-Warth 10, Ulrike von Arnim 11, Verena Keitel 12, Jürgen Lohmeyer 13, Karl-Georg Simon 14, Christian Trautwein 15, Andreas Trein 16, Dietrich Hüppe 17, Markus Cornberg 18, Frank Lammert 19, Patrick Ingiliz 20, Reinhart Zachoval 21, Holger Hinrichsen 22, Alexander Zipprich 23, Hartmuth Klinker 24, Julian Schulze Zur Wiesch 25, Anett Schmiedeknecht 26, Oana Brosteanu 26, Thomas Berg 27
 
13.Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States
 

J Viral Hepat. 2023 Feb 26. doi: 10.1111/jvh.13823. Online ahead of print.

Robert J Wong 1 2, Loralee Rupp 3, Mei Lu 4, Zeyuan Yang 2, Yihe G Daida 5, Mark Schmidt 6, Joseph A Boscarino 7, Stuart C Gordon 8, Amit S Chitnis 9
 
14.Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023
 

MMWR Recomm Rep. 2023 Mar 10;72(1):1-25. doi: 10.15585/mmwr.rr7201a1.

Erin E Conners 1, Lakshmi Panagiotakopoulos 1, Megan G Hofmeister 1, Philip R Spradling 1, Liesl M Hagan 1, Aaron M Harris 1, Jessica S Rogers-Brown 1, Carolyn Wester 1, Noele P Nelson 1; Contributors
 
15.Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States
 

Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.

Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
 
16.Chronic hepatitis B and HIV coinfection
 

Top Antivir Med. 2023 Mar 31;31(1):14-22.

Maria A Corcorran 1, Nina Kim 1
 
17.What will it take to cure hepatitis B?
 

Hepatol Commun. 2023 Mar 24;7(4):e0084. doi: 10.1097/HC9.0000000000000084.eCollection 2023 Apr 1.

Wen-Juei Jeng 1 2, Anna S F Lok 3
 
18.Missed opportunities for diagnosis of hepatitis B and C in individuals diagnosed with decompensated cirrhosis or hepatocellular carcinoma
 

J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16162. Online ahead of print.

George Mnatzaganian 1 2, Jennifer H MacLachlan 1 3, Nicole Allard 1 3, Chelsea Brown 1, Stacey Rowe 4 5, Benjamin C Cowie 1 3 6
 
19. Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial
 

Sex Transm Infect. 2023 Mar;99(2):140-142.doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8.

Paul Le Turnier 1 2 3, Isabelle Charreau 4, Audrey Gabassi 5 6, Diane Carette 4, Laurent Cotte 7, Gilles Pialoux 8, Cécile Tremblay 9, Bruno Spire 10, Marie-Laure Chaix 5 6, Laurence Meyer 4 11, Catherine Capitant 4, Constance Delaugerre 5 6, François Raffi # 12 2, Jean-Michel Molina # 6 13; ANRS IPERGAY study group
 
20. Chronic Hepatitis B Virus: What an Internist Needs to Know: Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation
 

Med Clin North Am. 2023 May;107(3):435-447. doi: 10.1016/j.mcna.2022.12.002.Epub 2023 Feb 20.

Peter D Block 1, Joseph K Lim 2
 
21.Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019
 

Med Care. 2023 Apr 1;61(4):247-253. doi: 10.1097/MLR.0000000000001825. Epub 2023 Feb 3.

Thi T Hang Pham 1, Mehlika Toy 1, David Hutton 2, William Thompson 3, Erin E Conners 3, Noele P Nelson 3, Joshua A Salomon 4, Samuel So 1
 
22.Prevalence of anti-hepatitis B core in men who have sex with men attending a sexual health clinic in Brighton, UK, from 2012 to 2019
 

Sex Health. 2023 Feb;20(1):92-95. doi: 10.1071/SH22120.

Mahmoud Gouda 1, Colin Fitzpatrick 1, Deborah Williams 1, Daniel Richardson 2
 
23.Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination
 

Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006.Epub 2023 Feb 13.

Giuseppina Brancaccio 1, Barbara Coco 2, Alessandra Nardi 3, Maria Giovanna Quaranta 4, Maria Elena Tosti 4, Luigina Ferrigno 4, Irene Cacciola 5, Vincenzo Messina 6, Luchino Chessa 7, Filomena Morisco 8, Michele Milella 9, Francesco Barbaro 10, Alessia Ciancio 11, Francesco Paolo Russo 12, Nicola Coppola 13, Pierluigi Blanc 14, Ernesto Claar 15, Gabriella Verucchi 16, Massimo Puoti 17, Anna Linda Zignego 18, Liliana Chemello 19, Salvatore Madonia 20, Stefano Fagiuoli 21, Alfredo Marzano 22, Carlo Ferrari 23, Pietro Lampertico 24, Vito Di Marco 25, Antonio Craxì 26, Teresa Antonia Santantonio 27, Giovanni Raimondo 5, Maurizia R Brunetto 2, Giovanni Battista Gaeta 28, Loreta A Kondili 29; PITER collaborating investigators
 
24.Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature
 

Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780.eCollection 2023.

Cesare Mazzaro 1, Riccardo Bomben 1, Marcella Visentini 2, Laura Gragnani 3, Luca Quartuccio 4, Francesco Saccardo 5, Marco Sebastiani 6, Davide Filippini 7, Gianfranco Lauletta 8, Giuseppe Monti 5, Valter Gattei 1
 
25.Evolving considerations for choice of hepatitis B vaccine
 

Am J Manag Care. 2023 Feb;29(1 Suppl):S3-S14. doi: 10.37765/ajmc.2023.89325.

Dalga D Surofchy 1, Neil Shieh, Iris Tam
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.